Nalmefene Hydrochloride Oral Tablets Suppliers & Bulk Manufacturers

Available Forms: Oral Tablets

Available Strengths: 18 mg

Reference Brands: Selincro(EU)

Category: Antipsychotropic Drugs

Nalmefene is an opioid receptor modulator that primarily acts as an antagonist at μ- and δ-opioid receptors and partial agonist at κ-opioid receptors. It reduces the rewarding effects of alcohol, helping to decrease consumption. Clinically, it's used in the management of alcohol dependence in adults with high-risk drinking behaviors. Nalmefene Hydrochloride Oral Tablets is available in Oral Tablets and strengths such as 18 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Nalmefene Hydrochloride Oral Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Nalmefene Hydrochloride Oral Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Nalmefene Hydrochloride Tablets are approved in the EU for the reduction of alcohol consumption in adult patients with alcohol dependence, under brand names like Selincro®. They are prescription-only and regulated by the European Medicines Agency (EMA) under centralized procedures. In the USA, as of now, Nalmefene tablets are not FDA-approved for alcohol dependence, though clinical trials have been conducted. EU regulatory approval includes risk management plans and post-marketing surveillance. Manufacturing requires adherence to EU-GMP guidelines. Pharmatradz.com connects you with compliant suppliers of Nalmefene Hydrochloride tablets and other psychiatric formulations for global B2B sourcing and regulatory insight.